DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/04/3205-479-483$20.00
DMD 32:479-483, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, Y.
Right arrow Articles by Yamamoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, Y.
Right arrow Articles by Yamamoto, T.

RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3

Yasuna Kobayashi, Naomi Ohshiro, Ayumi Tsuchiya, Noriko Kohyama, Masayuki Ohbayashi, and Toshinori Yamamoto

Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan (Y.K., A.T., N.K., M.O., T.Y.); and Department of Physiology and Biophysics, the University of Texas Medical Branch at Galveston, Galveston, Texas (N.O.)

Organic anion transporter 3 [Oat3(Slc22a8)] plays an important role in the renal handling of organic compounds. The substrate specificity of rat Oat3 and human Oat3 has been elucidated; information on mouse Oat3 (mOat3) is less defined. The aim of this study was to extend the substrate selectivity of mOat3. When expressed in Xenopus laevis oocytes, mOat3 mediated the uptake of p-aminohippuric acid and estron sulfate (ES). In addition to these substrates, we found that several organic compounds such as prostaglandin E2, prostaglandin F2{alpha}, allopurinol, 6-mercaptopurine (6-MP), 5-fluorouracil (5-FU), and L-carnitine are substrates of mOat3, compounds identified for the first time. The apparent Km values for the uptake of mOat3 that mediated the transport of 6-MP, 5-FU, and L-carnitine were 4.01 ± 0.7 µM, 53.9 ± 8.9 nM, and 61.9 ± 1.1 nM, respectively. Northern blot analysis revealed that gene coding for mOat3 is predominant in the kidney and, to a lesser extent, in the brain and the eye. Our findings thus provide further insights into the role of Oat3 in renal drug transport.


Address correspondence to: Dr. Toshinori Yamamoto, Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555. E-mail: yamagen{at}pharm.showa-u.ac.jp




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
Y. Murakami, N. Kohyama, Y. Kobayashi, M. Ohbayashi, H. Ohtani, Y. Sawada, and T. Yamamoto
FUNCTIONAL CHARACTERIZATION OF HUMAN MONOCARBOXYLATE TRANSPORTER 6 (SLC16A5)
Drug Metab. Dispos., December 1, 2005; 33(12): 1845 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Bahn, M. Ljubojevic, H. Lorenz, C. Schultz, E. Ghebremedhin, B. Ugele, I. Sabolic, G. Burckhardt, and Y. Hagos
Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1075 - C1084.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Kang, P. Chapdelaine, J. Parent, E. Madore, P. Y. Laberge, and M. A. Fortier
Expression of Human Prostaglandin Transporter in the Human Endometrium across the Menstrual Cycle
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2308 - 2313.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.